| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3038180
Max Phase: Preclinical
Molecular Formula: C36H46N6O5
Molecular Weight: 642.80
Molecule Type: Protein
Associated Items:
Representations
Canonical SMILES: Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C36H46N6O5/c1-22-16-27(43)17-23(2)28(22)20-29(38)36(47)42-21-26-13-7-6-12-25(26)19-32(42)35(46)40-30(14-8-9-15-37)34(45)41-31(33(39)44)18-24-10-4-3-5-11-24/h3-7,10-13,16-17,29-32,43H,8-9,14-15,18-21,37-38H2,1-2H3,(H2,39,44)(H,40,46)(H,41,45)/t29-,30-,31-,32-/m0/s1
Standard InChI Key: CGVRVIAPYFDFJZ-YDPTYEFTSA-N
Associated Targets(non-human)
Mu opioid receptor 3620 Activities
Delta opioid receptor 3127 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Kappa opioid receptor 4577 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Delta opioid receptor 3911 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mu opioid receptor 6060 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 642.80 | Molecular Weight (Monoisotopic): 642.3530 | AlogP: 1.66 | #Rotatable Bonds: 14 |
| Polar Surface Area: 193.87 | Molecular Species: BASE | HBA: 7 | HBD: 6 |
| #RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 9.62 | CX Basic pKa: 10.33 | CX LogP: 1.79 | CX LogD: -0.50 |
| Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.14 | Np Likeness Score: 0.01 |
References
| 1. Weltrowska G, Nguyen TM, Chung NN, Wilkes BC, Schiller PW.. (2013) N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile., 23 (18): [PMID:23932788] [10.1016/j.bmcl.2013.07.036] |
Source
Source(1):